Is the bullish run coming to an end? Fresenius Medical Care closed at $24 (-0.91%)

Though in the midst of a 7 day uptrend, gaining a total of 10.09%, ($2.42), Today's session suggests run might be coming to an end — the kidney dialysis specialist has recovered almost all of its session losses after dipping down to $23.86 today.

Fresenius Medical Care is currently trading at $24 following the release of ISM Manufacturing PMI (Apr) data from the United States.

Amid the market gloom, United States ISM Manufacturing PMI (Apr) released today at 14:00 UTC with a figure of 47.1, while the previous figure was 46.3. United States ISM Manufacturing Prices (Apr) came out at 53.2, while a consensus of analysts was expecting 49. United States ISM Manufacturing Employment (Apr) came out at 50.2, while a consensus of analysts was expecting 47.9.

Technical analysis shows that Fresenius Medical Care AG & Co. KGaA could begin to recover as it approaches significant support, now 9 cents away from $23.91. Dipping below could be an indication that further losses are ahead. Trend analysis indicates that investors are seeking long positions as Fresenius Medical Care price action surged above +100 — a key CCI threshold indicating an imminent bullish trend. According to asset volatility analysis, Fresenius Medical Care's upper Bollinger Band® is at $24.18 which indicates a further downward move may follow.

Overall, while Fresenius Medical Care has been on an uptrend, technical indicators suggest that it has no obvious direction for the immediate future.

On the other hand, positive performances could be seen by looking at other health care stocks as Eli Lilly and Company was up 2.51%. Bristol-Myers Squibb Company added 2.44% to its value, and traded at $68.4.

Furthermore, United States JOLTs Job Openings (Mar) will be released tomorrow at 14:00 UTC.

The kidney dialysis specialist has managed to gain 50.34% so far this year despite trading at lows around $12.81 previously.